3M

3M (NYSE: MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what’s possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn how we’re working to improve lives and make what’s next at 3M.com/news or on Twitter at @3M or @3MNews.

3M (NYSE:MMM) Stock Analyst Ratings

3M (NYSE:MMM) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/19/2023 5.63% Wells Fargo $100 → $112 Maintains Equal-Weight 12/04/2023 0.91% Barclays $98 → $107 Upgrades Underweight → Equal-Weight 10/25/2023 -0.97% JP Morgan $104 → $105 Maintains Neutral 10/25/2023 -21.72% RBC Capital $85 → $83 Maintains Underperform 10/25/2023 -8.52% Citigroup $95 → $97 Maintains Neutral 10/25/2023 -7.57% Barclays $96 → $98 Maintains Underweight 10/09/2023 -10.4% Citigroup $111 → $95 Maintains Neutral 09/15/2023 2.8% HSBC → $109 Initiates Coverage On → Hold 08/31/2023 6.57% Morgan Stanley $102 → $113 Upgrades Underweight → Equal-Weight 08/29/2023 13.17% Mizuho → $120 Reiterates Neutral → Neutral 08/29/2023 — Wolfe Research Upgrades Underperform → Peer Perform 07/26/2023 -3.8% Morgan Stanley $100 → $102 Maintains Underweight 07/26/2023 4.69% Citigroup $100 → $111 Maintains Neutral 07/26/2023 -5.69% RBC Capital $95 → $100 Maintains Underperform 07/14/2023 -5.69% Morgan Stanley $100 →

3M (NYSE:MMM) Stock Analyst Ratings Read Post »

3M (NYSE:MMM) Analyst Ratings

3M (NYSE:MMM) Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/04/2023 6.73% Barclays $98 → $107 Upgrades Underweight → Equal-Weight 10/25/2023 4.74% JP Morgan $104 → $105 Maintains Neutral 10/25/2023 -17.21% RBC Capital $85 → $83 Maintains Underperform 10/25/2023 -3.24% Citigroup $95 → $97 Maintains Neutral 10/25/2023 -2.24% Barclays $96 → $98 Maintains Underweight 10/09/2023 -5.24% Citigroup $111 → $95 Maintains Neutral 09/15/2023 8.73% HSBC → $109 Initiates Coverage On → Hold 08/31/2023 12.72% Morgan Stanley $102 → $113 Upgrades Underweight → Equal-Weight 08/29/2023 19.7% Mizuho → $120 Reiterates Neutral → Neutral 08/29/2023 — Wolfe Research Upgrades Underperform → Peer Perform 07/26/2023 1.75% Morgan Stanley $100 → $102 Maintains Underweight 07/26/2023 10.72% Citigroup $100 → $111 Maintains Neutral 07/26/2023 -0.25% RBC Capital $95 → $100 Maintains Underperform 07/14/2023 -0.25% Morgan Stanley $100 → $100 Reiterates Underweight → Underweight 07/11/2023 9.73% B of A

3M (NYSE:MMM) Analyst Ratings Read Post »

3M Expands Reseller Agreement With Smart Reporting to Include US

3M Co.’s (MMM) 3M Health Information Systems said Monday it has expanded its reseller agreement with Smart Reporting, a German technology provider in radiology and pathology reporting, in international markets to include the US. The collaboration helps expand 3M Health Information Systems’ portfolio of solutions, including 3M M*Modal Fluency for Imaging, the company said. The company said its 3M Fluency for Imaging solution complements Smart Reporting’s synoptic reporting, available in nine languages, in advancing speech-driven reporting and workflow management.

3M Expands Reseller Agreement With Smart Reporting to Include US Read Post »

CFRA Reiterates Hold Rating On Shares Of 3m Company

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target to $100 from $120, valuing shares at 11x our 2024 EPS (reduced to $9.13 from $9.25; 2023 EPS forecast lifted to $9.00 from $8.66). We use a lower multiple than MMM’s five-year forward P/E average of 16.3x to reflect litigation and regulatory risks stemming from safety and environmental issues with multiple 3M products. MMM shares are trading higher today following the company’s Q3 print; it posted an adjusted EPS of $2.68 vs. $2.60 (+3% Y/Y), which is above both consensus and the company’s original guidance ($2.25-$2.40). We attribute the beat to better-than-expected gains made on productivity, supply chain restructuring, cost savings, and pricing across each of MMM’s businesses. Softness in electronics, consumer retail, and China, as well as disposable respirator volumes, led

CFRA Reiterates Hold Rating On Shares Of 3m Company Read Post »

Scroll to Top